RUBY GOMEZ: Open Payments
NPI 1821595265 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,500 in 52 payments from 18 companies in 2025. Trend: 2023 $2,553 · 2024 $3,097 · 2025 $4,500
Food & beverage: $3,959Education: $539Speaker / faculty: $2
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $729 |
| AstraZeneca Pharmaceuticals LP | 5 | $518 |
| Lilly USA, LLC | 5 | $488 |
| Incyte Corporation | 3 | $345 |
| GENZYME CORPORATION | 2 | $286 |
| Daiichi Sankyo Inc. | 4 | $269 |
| PFIZER INC. | 3 | $259 |
| Fennec Pharmaceuticals, Inc. | 3 | $258 |
| ABBVIE INC. | 2 | $225 |
| Exelixis Inc. | 2 | $198 |
Products named: RYBREVANT, Enhertu, Pedmark, Monjuvi, Vonjo, WAYRILZ, BRAFTOVI, LIBTAYO.
Industry payments across TX — which companies pay providers there.
